Samrat Pharmachem Ltd.
BSE: 530125 | Sector: Health care |
NSE: N.A. | ISIN Code: INE103E01016 |
BSE 00:00 | 02 Mar | 151.45 |
-0.90 (-0.59%) |
OPEN
153.95 |
HIGH
153.95 |
LOW
148.50 |
NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
OPEN | 153.95 |
PREVIOUS CLOSE | 152.35 |
VOLUME | 5964 |
52-Week high | 159.00 |
52-Week low | 47.10 |
P/E | 11.23 |
Mkt Cap.(Rs cr) | 47 |
Buy Price | 150.55 |
Buy Qty | 22.00 |
Sell Price | 152.90 |
Sell Qty | 50.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Samrat Pharmachem Ltd. (SAMRATPHARMA) - Balance Sheet
Figures in Rs crore | 2020 | 2019 | 2018 |
Sources of Funds | |||
Share Capital | 3.09 | 3.09 | 3.09 |
Reserves | 21.21 | 16.98 | 15.44 |
Total Shareholders Funds | 24.30 | 20.07 | 18.53 |
Secured Loans | 9.41 | 6.53 | 9.39 |
Unsecured Loans | 0.00 | 0.20 | 0.20 |
Total Debt | 9.41 | 6.73 | 9.59 |
Total Liabilities | 33.71 | 26.80 | 28.12 |
Application of Funds | |||
Gross Block | 11.44 | 10.92 | 10.62 |
Capital Work in Progress | 1.08 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 |
Current Assets, Loans & Advances | |||
Inventories | 18.77 | 7.93 | 6.85 |
Sundry Debtors | 27.81 | 21.05 | 21.89 |
Cash and Bank | 1.17 | 2.25 | 3.98 |
Loans and Advances | 2.66 | 2.31 | 1.29 |
Total Current Assets | 50.41 | 33.54 | 34.01 |
Current Liabilities and Provisions | |||
Current Liabilities | 23.75 | 13.23 | 11.46 |
Provisions | 1.22 | 0.37 | 1.41 |
Net Current Assets | 25.44 | 19.94 | 21.14 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | N/A | N/A | N/A |
Deferred Tax Liability | N/A | N/A | N/A |
Net Deferred Tax | N/A | N/A | N/A |
Other Assets | 0.00 | 0.00 | 0.00 |
Total Assets | 33.71 | 26.81 | 28.13 |
Quick Links for Samrat Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices